HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Total Current Liabilities

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Total Current Liabilities

BEAT · NASDAQ
CompanyTotal Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
0.00
N/AN/AN/A 
2.93M
-52.6%-19.9%N/A
10.09M
-25.6%2.6%N/A
13.49M
-7.6%1.1%28.9%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
17.98M
1.9%11.2%N/A
20.06M
-4.7%2.7%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
3.80M
5.0%6.0%8.8%
28.58M
14.5%19.1%N/A
13.03M
4.6%-4.6%N/A
36.15M
23.1%24.9%N/A
4.63M
-42.8%5.8%N/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47